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Abstract 
 
Objective 
To determine the impact of bacteraemia on ICU mortality and develop a bacteremia 
prediction tool using Systemic Inflammatory Response Syndrome (SIRS) criteria.  
Participants 
Patients aged >18 who had blood cultures taken in the ICU 1st January 2011-31st 
December 2013. 
Design 
All patients meeting the above criteria were identified from microbiology department 
records of Glasgow Royal Infirmary, Scotland. Clinical and outcome data were 
gathered from ICU records. Patients with clinically significant bacteraemia were 
matched to controls using propensity scores. SIRS criteria were gathered and used 
to create decision rules to predict the absence of bacteraemia. 
Main outcome measures 
Mortality at ICU discharge. Sensitivity and accuracy of prediction of blood culture 
status by SIRS decision rule.  
Results 
One hundred patients had a clinically significant positive blood culture and were 
matched to 100 controls. Bacteraemic patients had higher ICU mortality (OR 2.35 
p=0.001) and longer ICU stay (17.0 vs. 7.8 days, p=<0.001). Of 1548 blood culture 
episodes, 1274 met ≥2 SIRS criteria (106 significant positive cultures, 1168 negative 
cultures). There was no association between SIRS criteria and positive blood 
cultures (p=0.11). A decision rule using three SIRS criteria had optimal predictive 
performance (sensitivity 56%; specificity 50%) but had low accuracy.  
Conclusion 
ICU patients with bacteraemia have increased mortality and length of ICU stay. SIRS 
criteria cannot be used to identify patients at low risk of bacteraemia.  
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Introduction 
 
Bacteraemia accounts for around 15% of all intensive care unit (ICU) infections [1]. 
Its most serious manifestation, septic shock, has a mortality of up to 70% [2]. There 
are conflicting reports in the literature concerning the outcomes of ICU patients with 
bacteraemia; for example, a Canadian study demonstrated that patients presenting 
to the ICU with bacteraemia did not have increased mortality compared to those 
without (OR 1.1 95% CI 0.7-1.8) [3]. This contrasts with studies by Prowle et al and 
Lambert et al which found that bacteraemia was independently associated with an 
increase in mortality rate in ICU patients of three and two-four fold respectively [4,5]. 
Accurate diagnosis and management of a sepsis episode is vital in order to reduce 
mortality and improve antimicrobial stewardship efforts.  
Blood cultures are the current gold-standard for detecting bacteraemia [2]. Collection 
of diagnostic information from blood cultures must be balanced with appropriate 
testing intervals and frequency to maximize the accuracy and usefulness of the 
procedure [6]. Obtaining and processing blood cultures that are frequently negative 
increases the risk of false-positive results, which may lead to increased patient length 
of stay, exposure to inappropriate antimicrobials and increased laboratory time and 
costs [6,7]. Untreated bacteraemia, however, leads to septic shock and positive 
blood cultures allow rationalization of empiric antimicrobial therapy [8]. The ability to 
simply and accurately assess the risk of bacteraemia would be useful when deciding 
whether to take blood cultures. Previous work has indicated that the Systemic 
Inflammatory Response Syndrome (SIRS) is a sensitive indicator of the presence of 
bacteraemia in general medical patients [3,9,10].  
The aim of this study was to investigate the mortality of ICU patients with 
bacteraemia and the relationship between SIRS status and blood culture status in 
ICU patients.  
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Materials and methods 
Study setting and population 
This study was conducted in Glasgow Royal Infirmary, a tertiary referral 
hospital Scotland with a 20 bed mixed medical/surgical ICU that admits 
approximately 1,200 patients annually. All blood cultures taken in patients 
aged ≥18 years old between 1st January 2011 and 31st December 2013 were 
included. Eligible patients were identified from microbiology laboratory 
records. The retrospective, non-interventional nature of this study meant that 
Research Ethics approval was not required. 
Data analysis 
ICU based data 
The following variables were collected about patients: age, gender, APACHE II 
score, admitting specialty (medical vs. surgical), result of blood culture, organism(s) 
isolated and length of ICU and total hospital stay.  
SIRS data collection 
The number of SIRS criteria a patient met at the time of each blood culture episode 
was recorded and episodes were assigned a score from 0-4 depending of the 
number of criteria met. SIRS criteria were defined as those established by Bone et al 
for the Society of Critical Care Medicine/American College of Chest Physicians (see 
Table 1) [11]. Patients were also classified by severity of infection at the time of their 
first positive blood culture according to the criteria in Table 1. Each blood culture 
episode was defined as a 48-hour period beginning when a blood culture was drawn. 
Additional blood cultures drawn within these 48 hours were considered part of the 
initial episode. If additional cultures were drawn after 48 hours had passed, this was 
considered a new episode and the number of SIRS criteria met was recorded again.  
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Table I: Details of the systemic inflammatory response syndrome criteria and 
different severity of infection based on this, as described by Bone et al. [11] 
Syndrome Clinical signs 
SIRS Two or more of the following: 
 Heart rate >90 bpm 
 Respiratory rate >20 breaths per minute or 
PaCO2 <4.3kPa.  
 Temperature <36C/>38C 
 White cell count <4x109/L/>12x109/L 
Sepsis Two SIRS criteria due to infection 
Severe sepsis Sepsis with evidence of organ dysfunction 
Septic shock Severe sepsis with hypotension not 
responsive to fluid resuscitation 
 
Mortality data 
The mortality difference between bacteraemic and non-bacteraemic patients was 
analysed at ICU discharge, hospital discharge and 90 days post ICU admission. 
Length of stay comparison was done using only surviving patients and calculated for 
ICU stay and total hospital stay. 
Microbiology laboratory data 
Positive blood cultures were assessed for clinical significance by the researcher 
collecting the data. In line with previous studies, gram-negative organisms were 
considered to represent clinically significant infection [12] and single isolates of 
coagulase-negative staphylococci, Propionibacterium acnes and Corynebacterium 
species were classified as contaminants [13–15]. Multiple isolates of these 
organisms or other common skin commensals were reviewed by a clinical 
microbiologist and, taking into account diagnosis and clinical course, were 
subsequently classified as representing contamination or clinically significant 
infection. Generally, isolates commonly representing contamination were only 
considered significant if isolated from two or more consecutive cultures taken on 
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different days and with a clinical history consistent with infection. A patient who had a 
true positive blood culture at any point in their ICU stay was classified as 
bacteraemic.  
Statistical analysis 
Two-sided p-values of <0.05 were considered significant for all comparisons. 
Calculations were done using SPSS version 22.0 (IBM, New York, United 
States). Bacteraemic patients were matched to negative controls on a one-to-
one ratio using propensity scoring in R (R Foundation for Statistical 
Computing, Vienna, Austria) with the optimal matching method. Propensity 
scoring is a method whereby baseline covariates are assigned a numerical 
value with the summation of the values of all baseline covariates being the 
propensity score for a given individual. Thus a set of subjects with the same 
propensity score will have equal distribution of baseline coavariates [16,17]. 
Controls were matched to positive patients based on who had the closest 
propensity score. In the optimal match method, this is done so as to produce 
the smallest total difference of propensity scores between the entire matched 
and control cohorts [17]. Controls were matched based on four variables 
identified from a Delphi process of intensive care consultants: age, APACHE 
II score, gender and admitting specialty. Continuous variables were compared 
using Student’s t-test or the Mann-Whitney U test. Categorical variables were 
compared using the chi-square test. The odds ratio (OR) of death in 
bacteraemic compared to negative patients was calculated using logistic 
regression. Survival at 90 days post ICU admission was also compared using 
Kaplan-Meier curves. The chi-square test was used to test for association 
between meeting the criteria for SIRS and positive blood culture episodes. To 
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assess the ability of SIRS status to predict blood culture outcome, a series of 
decision rules were created with each sequential level of SIRS criteria bring 
set in turn as a cut-off point to consider that episode as ‘likely to be positive’ or 
‘unlikely to be positive’ with these classifications subsequently compared to 
actual blood culture results for each level of SIRS criteria. Sensitivity and 
specificity of each level of SIRS criteria were calculated.  
Results 
Between January 1st 2011 and December 31st 2013, 2819 patients were admitted to 
the ICU of which 813 had at least one blood culture taken.  
One or more microorganisms were isolated from the cultures of 165 patients 
(20.3%), of which 100 (12.3%) were determined to be clinically significant. Clinical 
and demographic characteristics of patients are detailed in Table 1. Compared to 
patients with negative blood cultures, patients with clinically significant bacteraemia 
were more likely to have been admitted to the ICU from a surgical specialty and had 
a higher mean APACHE II score.  
 
Table II: Comparison of demographic and clinical data between bacteraemia-positive 
and bacteraemia-negative patients 
Variable Bacteraemic 
patients n=100 
Negative patients n=713 P-value 
    
Male sex 58 (58%) 420 (58.3%) 0.863 
Mean age  56.2±14.6 57.6±15.9 0.429 
Medical admission 33 (33%) 343 (48.1%) 0.006 
APACHE II score  22.1±8.2 19.9±7.4 0.006 
Infective status *    
Infected 1 (0.9%) - - 
Sepsis 14 (14%) - - 
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Severe sepsis 50 (50%) - - 
Septic shock 40 (40%) - - 
*At time of index positive blood culture according to criteria defined by Bone et al [11] 
 
Details of microorganisms isolated from positive blood cultures are summarised in 
Table 2. The most common isolates were Enterococcus species (n=49, 23%), 
Escherichia coli (n=46, 21%) and clinically significant coagulase-negative 
staphylococci, where it represented clinically significant infection (n=24, 11%).  
Table III: Clinically significant microorganisms isolated from positive blood cultures 
Gram Positive (n=110) 
Staphylococcus aureus 31 
Coagulase-negative staphylococci 24 
Enterococcus spp.  49 
Streptococcus pneumoniae 1 
  
Streptococcus spp. (S. anginosus & S. 
mitis groups) 
2 
Clostridium spp.  2 
Bacillus spp. 1 
 
Gram negative (n=89) 
Escherichia coli 46 
Klebsiella spp. 12 
Other enteric gram-negative rods 25 
Gram-negative anaerobes  6 
 
Yeasts (n=18) 
Candida albicans 12 
Other Candida species 5 
Other yeasts 1 
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Total                                                         217 
 
Patients with a significant bacteraemia were assigned and matched to 100 negative 
controls. The data in Table 3 details the mortality and length of stay for all patients in 
the study. After excluding patients who died, those with bacteraemia had a longer 
ICU stay than controls (median time 17.0 vs. 7.8 days, p=<0.001) as well as a longer 
total hospital stay (median time 49.5 vs. 22.1 days, p=0.05). Compared to matched 
controls, bacteraemic patients had a higher risk of mortality at ICU discharge (OR 
2.35 (95% CI 1.45-3.83), p=0.001) and at hospital discharge (OR 2.70 (95% CI 1.67-
4.34), p=<0.001). Seven patients (3.5%) had an ICU stay longer than 90 days of 
which two (both bacteraemic) were discharged alive. Fifteen patients (7.5%) had a 
total hospital stay longer than 90 days of which 11 were discharged alive (two 
negative, nine bacteraemic). At 90 days follow-up, patients with bacteraemia had 
reduced survival with analysis using Kaplan-Meier curves (figure I) demonstrating 
this difference occurs primarily between 20 and 40 days post ICU admission. An 
analysis with bacteraemic patients stratified into Gram positive, Gram negative, 
polymicrobial and fungal cohorts did not demonstrate increased mortality at any point 
compared to controls for any of these individual groups. 
 All patients 
n=813 
Bacteraemic 
patients n=100 All negative 
patients 
n=713 
P-value 
Mortality 
At ICU discharge 215 (26.4%) 42 (42.0%) 173 (24.3%) <0.001 
At hospital 
discharge 
262 (32.2%) 52 (52.0%) 210 (29.5%) <0.001 
90 days - 64 (64.0%) 41 (41.0%)* <0.001* 
Median length of stay (days) 
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Table IV: Comparison of mortality and length of stay between bacteraemia-
positive patients and matched controls 
 
 
Figure I: Kaplan-Meier curve comparing survival analysis to 90 days in patients with 
bacteraemia to matched controls 
 
 
Descriptive data for blood cultures and relationship to SIRS status is detailed in 
Table 4. A total of 1548 blood culture episodes were recorded in the study period: 
124 (8.1%) were true positive, leaving 1424 (including contaminants; 91.9%) 
classified as negative. One-hundred-and-six (84.8%) positive episodes met at least 
two SIRS criteria as did 1168 (81.2%) negative episodes. There was no association 
ICU 7 (3-14) 17 (5.7-30.8) 6.8 (3-13) <0.001 
Total hospital 20 (11-46) 49.5 (33.3-
75.2) 
20 (11-36.5) 0.004 
*only negative patients selected as matched to positives 
 11 
between meeting ≥2 SIRS criteria and the result of a blood culture episode 
(p=0.109). 
Table V: Breakdown of the number of blood culture episodes and the 
performance the decision rule by different levels of SIRS criteria for all blood 
culture episodes 
Blood culture episodes  1548 
Blood cultures  2738 
True positive  242/2738 (8.8%) 
Contaminant  212/2738 (7.7%) 
Negative  2284/2738 (83.4%) 
Blood culture 
sets/episode 
1 807 (52.1%) 
 2 347 (22.4%) 
 3 342 (22.1%) 
 >4 53 (3.4%) 
Indication Pyrexia 786 (50.8%) 
 Inflammation*  180 (11.6%) 
 Sepsis† 303 (19.6%) 
 Other 77 (5%) 
 Unclear 197 (12.7%) 
   
SIRS criteria by 
episode type 
 Positive Negative 
SIRS 4 17 (13.6%) 208 (14.6%) 
 3 51 (40.8%) 505 (35.5%) 
 2 38 (30.4%) 455 (32.0%) 
Non-SIRS 1 11 (8.8%) 191 (13.4%) 
 0 7 (5.6%) 65 (4.6%) 
* Defined as raised C-reactive protein or white cell count. 
† Includes suspected sepsis or focal infection 
 
 12 
Using a decision rule that required two SIRS criteria to be present before ordering 
blood cultures in order to model prediction of positive blood culture status created an 
‘unlikely to be positive’ cohort of 274 (17.7%) episodes. This rule had a sensitivity of 
87%, a specificity of 18% and would have prevented 256 (18%) negative episodes 
(272 blood cultures) but missed 18 (13%) positive episodes (31 blood cultures, 18 
patients). A decision rule requiring three SIRS criteria was identified from a ROC 
curve as providing optimal trade-off between sensitivity (56%) and specificity (50%) 
and created an ‘unlikely’ cohort of 767 (49%) episodes. This would have prevented 
708 (49.7%) negative episodes (1172 blood cultures) with 59 (47%) positive 
episodes (108 blood cultures, 52 patients) missed. One and four criteria rules had a 
sensitivity of 95% and 15%, prevented 65 (4%) (90 cultures) and 1208 (78%) (2064 
cultures) and missed 7 negative episodes (0.4%) (15 cultures, 7 patients) and 115 
(92%) (229 cultures, 90 patients) positive episodes respectively. No level of SIRS 
criteria significantly increased the odds of a blood culture episode being positive.  
Discussion  
This study has demonstrated that bacteraemia increases mortality and length of stay 
among survivors compared to matched controls in a general ICU population. Several 
other authors have also investigated this, with some finding that bacteraemia does 
not increase mortality [3,14,18] and others concluding it does [4,5,19]. This may be 
because the observed impact of bacteraemia varies with study population and 
setting. By using propensity scoring to assign controls and by including all patients 
with bacteraemia, we tried to avoid these limitations. Due to the difficulty in 
establishing where an infection was acquired, we did not stratify analysis by 
community and nosocomial acquired infection. The use of propensity scores helped 
account for likely confounders of mortality differences between cohorts. Our primary 
aim was to determine whether bacteraemia, specifically, increases ICU patient 
mortality after controlling for confounders, not to identify predictors of mortality 
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amongst patients who have blood cultures taken. For these reasons a multivariate 
analysis to identify independent predictors of mortality was not done.  
Subgroup analysis of mortality by gram stain result or specific organisms would be 
desirable to show that some bacteraemias are likely more severe than others. When 
bacteraemic patients were divided into sub-cohorts based on gram stain results, no 
cohort demonstrated a statistically significant increase in mortality compared to 
controls. This is probably because there were not sufficient numbers in each cohort 
to allow a small increase in mortality to be demonstrated. Because of this, analysis 
by individual organism was not performed.  
Survival analysis showed that survival in the two cohorts was similar until the 20th day 
of ICU stay. In our analysis we did not match controls based on length of stay prior to 
bacteraemia. This was because matching factors were identified prospectively using 
a Delphi process, in which length of stay prior to infection was not identified. 
Furthermore, we were careful to avoid ‘overmatching’; trying to match controls based 
on too many variables, as this runs the risk of not being able to match controls for all 
cases. Length of stay prior to infection however, may be an important confounder to 
our results as it is possible that patients with increased length of stay are more 
severely ill and this puts them at increased both of acquiring nosocomial bacteraemia 
and death.  
In the bacteraemic cohort 90 patients (86%) met severe sepsis/septic shock criteria, 
which are known independent risk factors for death in ICU [20]. Our controls were not 
matched with respect to sepsis severities; it is possible the increased mortality 
observed may be due to a greater number of severely septic/shocked patients in the 
bacteraemic cohort.  
Whilst others have also investigated the mortality of ICU bacteraemia, our findings 
are nonetheless valuable. Because the United Kingdom has the smallest number of 
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ICU beds/population in developed world [21] a smaller percentage of the hospital 
population will accommodated there and as such may be sicker at baseline and more 
susceptible to the effects of bacteraemia. Previous investigations have predominantly 
taken place outside the UK [7,15,18] or have been limited tonosocomial acquired 
infection [5,19] or specific organisms [4] and thus their results may not be applicable 
to this population. These results, including all patients with bacteraemia in a general 
ICU population provide up-to-date knowledge of the impact bacteraemia. This is 
crucial to allow better prognostication and highlights bacteraemia treatment as a 
crucial therapeutic aim. 
We also investigated the relationship between SIRS status and blood culture result, 
as prior work in the non-ICU [3,9,10] setting has suggested that the presence of 
SIRS is closely linked with bacteraemia and as such might be utilised to be used to 
predict the presence of bacteraemia and thus avoid unnecessary blood cultures in 
patients who are unlikely to be bacteraemic [6].  
A blood culture decision rule should either be able to identify most negative patients 
whilst not missing any positives (good sensitivity and high specificity) or be highly 
sensitive (exclude most negative patients). No decision rule in our results performed 
adequately for clinical practice: three criteria provided optimal sensitivity and 
specificity trade-off, but missed too many positives; two criteria had a higher 
sensitivity (86%) and would have resulted in a respectable reduction in negative 
blood cultures but still missing 11 bacteraemic patients. Given the consequences of 
missing a bacteraemic episode we feel this is still too high. Analysing SIRS criteria 
was a secondary aim of this study and intended to investigate, in ICU patients, 
specific claims that SIRS criteria can be used as a decision rule about when to order 
blood cultures. We did not aim to identify all factors predictive of blood culture status 
and so multivariate analysis was not performed.  
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The poor ability of SIRS to predict blood culture status in the ICU is probably 
because ICU patients are exposed to a wider range of SIRS causing stimuli than 
other patients. The advantages of being able to predict the blood culture status of 
patients are clear, in particular the ability to reduce the number of ultimately negative 
cultures drawn would save money and reduce the risks to patients posed to by 
contaminant blood cultures. SIRS would have provided a simple, well-known basis 
for such a decision rule to be based upon. 
Limitations of this study include the single centre study design – Glasgow Royal 
Infirmary is a tertiary referral centre for pancreatitis and burns patients, both of which 
frequently require intensive care admission - therefore our results may not be 
generalizable to other centres. No data were collected on antimicrobial therapy. Both 
initially receiving inappropriate antimicrobials and a delay in receiving appropriate 
antimicrobials have been shown to increase mortality in patients with bacteraemia 
[15,22] – it is possible this could have confounded our assessment of mortality. 
Finally, although a small number of initially positive isolates were of questionable 
clinical significance, no inter-reliability testing was performed between investigators 
when classifying isolates as contamination vs. clinically significant. It is possible 
some isolates were thus misclassified, which may have affected the observed impact 
of bacteraemia in the clinically significant group.  
Conclusions 
This study helps clarify the contradictions regarding impact of bacteraemia on 
mortality and length of stay of ICU patients that exists within the literature by using 
propensity scoring to provide more evidence that bacteraemia increases mortality in 
ICU patients. It also refutes the suggestion that SIRS criteria could be used to predict 
blood culture status.  
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